MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Cefaclor

Cefaclor 375mg modified-release tablets

Use with caution

Stability notes for Cefaclor 375mg modified-release tablets

Light sensitive medicine. Store in light resistant container.   No stability data in MCAs available.

Provenance

This recommendation is based on the products Distaclor 375mg modified release tablets (Flynn Pharma Ltd) and Cefaclor 375mg modified release tablets (Flynn Pharma Ltd).

Supplier

Cefaclor 375mg modified-release tablets (Flynn Pharma Ltd)

Cefaclor 500mg capsules

Use with caution

Stability notes for Cefaclor 500mg capsules

Light sensitive medicine. Store in light resistant container.   Moisture sensitive medicine. Store in airtight (sealed) MCA. Anecdotal reports of use in MCAs (low quality evidence).

Provenance

This recommendation is based on the products Cefaclor 500mg capsules (Flynn Pharma Ltd).

Supplier

Cefaclor 500mg capsules (Flynn Pharma Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.